Home > Boards > US Listed > Medical - Drugs > AcelRx Pharmaceuticals, Inc. (ACRX)

http://ir.acelrx.com/news-releases/news-release-details/acelrx-receives-european-commission-approval

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JB3729 Member Profile
 
Followed By 83
Posts 3,868
Boards Moderated 0
Alias Born 02/15/10
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/24/2022 4:21:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/12/2022 4:02:49 PM
AcelRx Pharmaceuticals Announces Publication of an Editorial by an Internationally Recognized Leader in Opioid-Sparing Surgery Highlighting the Potential Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery PR Newswire (US) - 1/12/2022 8:30:00 AM
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics PR Newswire (US) - 1/10/2022 8:30:00 AM
AcelRx Pharma's sufentanil reduces hospital stay, opioid utilization in joint replacement surgery Seeking Alpha - 12/15/2021 8:53:31 AM
AcelRx Pharmaceuticals Announces Publication of Clinical Data Showing Reduced Hospital Length of Stay and Reduced Opioid Utilization with Use of Sublingual Sufentanil in Total Joint Replacement Surgery PR Newswire (US) - 12/15/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/3/2021 4:49:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2021 5:43:16 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/23/2021 5:39:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2021 5:32:36 PM
AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors PR Newswire (US) - 11/23/2021 5:09:00 PM
AcelRx launches ~$14M securities offering Seeking Alpha - 11/15/2021 9:59:41 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/15/2021 7:34:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 6:56:58 AM
AcelRx Announces $14 Million Registered Direct Common Stock and Warrant Offering PR Newswire (US) - 11/15/2021 6:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 6:39:31 AM
AcelRx Pharma to acquire Lowell Therapeutics Seeking Alpha - 11/15/2021 6:12:59 AM
AcelRx Pharmaceuticals EPS in-line, misses on revenue Seeking Alpha - 11/15/2021 6:02:05 AM
AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results PR Newswire (US) - 11/15/2021 6:00:00 AM
AcelRx to Host Third Quarter 2021 Financial Results Call and Webcast on November 15, 2021 PR Newswire (US) - 11/10/2021 8:30:00 AM
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors GlobeNewswire Inc. - 10/4/2021 7:30:00 AM
AcelRx Pharmaceuticals to Participate in Two September Investor Conferences PR Newswire (US) - 9/10/2021 3:19:00 PM
Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery Event PR Newswire (US) - 8/30/2021 8:30:00 AM
Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery Event PR Newswire (US) - 8/26/2021 8:30:00 AM
Understanding AcelRx Pharma’s Risk Factors Post Q2 TipRanks - 8/25/2021 9:17:25 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences